Symbol="BEAM"
AssetType="Common Stock"
Name="Beam TherapeuticsÂ Inc"
Description="Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1745999"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="26 LANDSDOWNE STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1861980000"
EBITDA="-364484000"
PERatio="None"
PEGRatio="None"
BookValue="10.71"
DividendPerShare="0"
DividendYield="0"
EPS="-4.58"
RevenuePerShareTTM="1.107"
ProfitMargin="0"
OperatingMarginTTM="-4.758"
ReturnOnAssetsTTM="-0.172"
ReturnOnEquityTTM="-0.37"
RevenueTTM="80160000"
GrossProfitTTM="-250674000"
DilutedEPSTTM="-4.58"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.208"
AnalystTargetPrice="63.93"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="32.42"
PriceToBookRatio="4.426"
EVToRevenue="24.39"
EVToEBITDA="-7.47"
Beta="1.56"
num_52WeekHigh="61.4"
num_52WeekLow="22.7"
num_50DayMovingAverage="28.64"
num_200DayMovingAverage="35.65"
SharesOutstanding="79200000"
DividendDate="None"
ExDividendDate="None"
symbol="BEAM"
open="23.49"
high="23.68"
low="23.03"
price="23.18"
volume="758569.00"
latest_trading_day="2023-08-31"
previous_close="23.51"
change="-0.33"
change_percent="-1.4037%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="63"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="37"
Volume_recent_avg="829559"
Change_recent_avg="-0.08"
Delta_recent_avg="1.35"
Variance_recent_avg="0.67"
Change_ratio_recent_avg="-0.31"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="37"
Aroon_momentum_negative="63"
image_negative_thumbnail_id_1="158"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0018.jpeg"
image_negative_thumbnail_id_2="516"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0089.jpeg"
image_neutral_thumbnail_id_1="538"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_neutral_thumbnail_id_2="570"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_positive_thumbnail_id_1="1015"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0177.jpeg"
image_positive_thumbnail_id_2="602"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0106.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
